Hong Kong and Taiwan opening recently may have a small boost for GenS and GenM. This would not show in the next QR, which is due in Nov, only in Feb QR. On this reopening, Feb QR will maybe only reflect 2 months out of 3, but probably has some meat in there.
Forbes : Bear will end on... 19 Oct 2022 on historical average of 289 days...matter of 11 days time or slightly longer if on other side of the average..
These sharp downs are Hedge fund shorts and rip rally later.
So it seems Mashpee had some legal blockage from some anti-casino citizens in Taunton Now the wait is on the legal battle between Taunton anti-casino members with the Fed/Mashpee
Yawning. Zzzzzzzz. Where is Rm6 and above Rm6? My neck already long. My hair grew white colour. My eyes sleepy Zzzzzzzzzzz. Waiting for almost 3 years for Rm6 also couldn’t reach Rm6.
Posted by AngTayKor > 2022-06-05 01:14 | Report Abuse
Wait... I spotted something strange. Taurx is phrasing the words like this: "decline at a rate substantially less than is typical in Alzheimer’s based on published research."
This statement means that Taurx is comparing their active dose patient's performance in Lucidity trial VS the historical average score for all the placebo patients' for all the previous phase 3 clinical trials done by all other drug companies. I have been attending Taurx's AGMs every year, I have seen this term being used in Taurx's AGM's slides and I am able to comprehend what this announcement statement's phrasing actual meaning.
If Taurx is comparing their active dose's patient performance VS their own trial placebo patient group like in a phase 3 clinical trial scenario, the sentence phrasing should be read as: "decline at a rate substantially less than the trial's placebo patient group."
My personal view is that most likely Lucidity's placebo patient group somehow strangely has a stronger performance when compared to the historical average performance of all the previous phase 3 trials placebo patient group. Lucidity's placebo patient group is receiving the first generation MTC formula in very low dose. This is to make the real active dose pill and the placebo fake pill look and taste exactly the same, including for possible urine discolouration side effects. 18 years ago when I invested in Taurx, private equity investors will joking call this the "Blue Pee Pill". I think there could be some minority cases of minor positive drug effect here even at low dose MTC formula. It is very difficult to formulate a placebo fake pill that looks, taste and pee out in blue like the real pill.
Now I think the real trial result to be announced is going to be below my expected trial result score. This placebo pill become active dose is not a new issue. Taurx experienced this problem before back in 2016 when placebo pill HMTM 4mg was later discovered to be an active dose with powerful drug effects. Because of this placebo pill issue, the entire phase 3 clinical trial failed. I have mentioned abt this before in my earlier post. At that time, Taurx failed to realise that HMTM is actually 60 times the power of MTC formula. They thought its was like 30% more powerful than MTC. Some gross miscalculation then, very painful lesson learned, US$200m trial cost burned just like that, lost 6 years of drug development time.
The IMF now expects emerging Asian economies to grow 4.4% this year and 4.9% in 2023..
The Association of Southeast Asian Nations economies of Indonesia, Malaysia, the Philippines, Singapore, and Thailand (ASEAN-5) are expected to expand 5.3% this year from growth of 3.4% in 2021, the IMF report said. Growth was projected to slow to 4.9% in 2023 due to weaker demand in major trading partners such as China, the euro area and the United States.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DestinyL
4,746 posts
Posted by DestinyL > 2022-10-08 10:27 | Report Abuse
https://www.thestandard.com.hk/breaking-news/section/4/195366/Rules-on-cross-border-travel-may-be-relaxed-after-20th-National-Congress
I think this has better chance to strike than expecting Taurx to give Genting a boost by early 2023